Increased galectin-7 gene expression in lymphoma cells is under the control of DNA methylation

Biochemical and Biophysical Research Communications

Volumn 387, Issue 3, 2009, Pages 425-429

  Demers, Mélanie ^a   Couillard, Julie ^a   Giglia Mari, Giuseppina ^c   Magnaldo, Thierry ^b   St Pierre, Yves ^a  

^a INRS INSTITUT ARMAND FRAPPIER   (Canada)

^b CNRS   (France)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

DNA methylation; Galectin 7; Lymphoma; p53

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BIOLOGICAL MARKER; CYCLIN DEPENDENT KINASE INHIBITOR 1; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DOXORUBICIN; GALECTIN 7; GENOMIC DNA; PROTEIN P53; RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DNA METHYLATION; DNA SEQUENCE; GALECTIN 7 GENE; GENE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LYMPHOMA CELL; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; RESTRICTION MAPPING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; GALECTINS; GENE EXPRESSION; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LYMPHOMA; PROMOTER REGIONS, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 68249113456     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.07.015     Document Type: Article

References (27)

1. Liu F.T., and Rabinovich G.A. Galectins as modulators of tumour progression. Nat. Rev. Cancer 5 (2005) 29-41
2. Madsen P., Rasmussen H.H., Flint T., Gromov P., Kruse T.A., Honore B., Vorum H., and Celis J.E. Cloning, expression, and chromosome mapping of human galectin-7. J. Biol. Chem. 270 (1995) 5823-5829
3. Magnaldo T., Bernerd F., and Darmon M. Galectin-7, a human 14-kDa S-lectin, specifically expressed in keratinocytes and sensitive to retinoic acid. Dev. Biol. 168 (1998) 259-271
4. Magnaldo T., Fowlis D., and Darmon M. Galectin-7, a marker of all types of stratified epithelia. Differentiation 63 (1998) 159-168
5. Cao C., Said N., Amin S., Wu H.K., Bruce A., Garate M., Hsu D.K., Kuwabara I., and Liu F.T. Galectins-3 and -7, but not galectin-1, play a role in re-epithelialization of wounds. J. Biol. Chem. 277 (2002) 42299-42305
6. Cao Z., Said N., Wu H.K., Kuwabara I., Liu F.T., and Panjwani N. Galectin-7 as a potential mediator of corneal epithelial cell migration. Arch. Ophthalmol. 121 (2003) 82-86
7. Bernerd F., Sarasin A., and Magnaldo T. Galectin-7 overexpression is associated with the apoptotic process in UVB-induced sunburn keratinocytes. Proc. Natl. Acad. Sci. USA 96 (1999) 11329-11334
8. Polyak K., Xia Y., Zweier J.L., Kinzler K.W., and Vogelstein B. A model for p53-induced apoptosis. Nature 389 (1997) 300-305
9. Rorive S., Eddafali B., Fernandez S., Decaestecker C., André S., Kaltner H., Kuwabara I., Liu F.T., Gabius H.J., Kiss R., and Salmon I. Changes in galectin-7 and cytokeratin-19 expression during the progression of malignancy in thyroid tumors: diagnostic and biological implications. Mod. Pathol. 15 (2002) 1294-1301
10. Saussez S., and Kiss R. Galectin-7. Cell. Mol. Life Sci. 63 (2006) 686-697
11. Moisan S., Demers M., and Mercier J. Upregulation of galectin-7 in murine lymphoma cells is associated with progression toward an aggressive phenotype. Leukemia 17 (2003) 751-759
12. Demers M., Magnaldo T., and St-Pierre Y. A novel function for galectin-7: promoting tumorigenesis by up-regulating MMP-9 gene expression. Cancer Res. 65 (2005) 5205-5210
13. Demers M., Biron-Pain K., Hébert J., Lamarre A., Magnaldo T., and St-Pierre Y. Decreased dissemination of T cell lymphoma by inhibition of galectin-7. Cancer Res. 67 (2007) 2824-2829
14. Benvenuto G., Carpentieri M.L., Salvatore P., Cindolo L., Bruni C.B., and Chiariotti L. Cell-specific transcriptional regulation and reactivation of galectin-1 gene expression are controlled by DNA methylation of the promoter region. Mol. Cell. Biol. 16 (1996) 2736-2743
15. Ruebel K.H., Jin L., Qian X., Scheithauer B.W., Kovacs K., Nakamura N., Zhang H., Raz A., and Lloyd R.V. Effects of DNA methylation on galectin-3 expression in pituitary tumors. Cancer Res. 65 (2005) 1136-1140
16. Aoudjit F., Potworowski E.F., and St-Pierre Y. The metastatic characteristics of murine lymphoma cell lines in vivo are manifested after target organ invasion. Blood 91 (1998) 623-629
17. Brown J.P., and Pagano M. Mechanisms and degradation. Biochem. Biophys. Acta 1332 (1997) 1-6
18. Troester M.A., Hoadley K.A., Sorlie T., Herbert B.S., Borresen-Dale A.L., Lonning P.E., Shay J.W., Kaufmann W.K., and Perou C.M. Cell-type-specific responses to chemotherapeutics in breast cancer. Cancer Res. 64 (2004) 4218-4226
19. El-Deiry W.S., Tokino T., Velculescu V.V., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., and Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 75 (1993) 817-825
20. 1 cyclin-dependent kinases. Cell 75 (1993) 805-816
21. Dumaz N., Duthu A., Ehrhart J., Drougard C., Appella E., Anderson C., May P., Sarasin A., and Daya-Grosjean L. Prolonged p53 protein accumulation in trichothiodystrophy fibroblasts dependent on unrepaired pyrimidine dimers on the transcribed strands of cellular genes. Mol. Carcinog. 20 (1997) 340-347
22. Petitjean A., Mathe E., Kato S., Ishioka C., Tavtigian S.V., Hainaut P., and Olivier M. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum. Mutat. 28 (2007) 622-629
23. Rhee I., Jair K.W., Yen R.W., Lengauer C., Herman J.G., Kinzler K.W., Vogelstein B., Baylin S.B., and Schuebel K.E. CpG methylation is maintained in human cancer cells lacking dnmt1. Nature 404 (2000) 1003-1007
24. Raimond J., Rouleux F., Monsigny M., and Legrand A. The second intron of the human galectin-3 gene has a strong promoter activity down-regulated by p53. FEBS Lett. 363 (1995) 165-169
25. Poirier F., Bourin P., Bladier D., Joubert-Caron R., and Caron M. Effect of 5-azacytidine and galectin-1 on growth and differentiation of the human B lymphoma cell line bl36. Cancer Cell Int. 1 (2001) 2
26. Chicoine E., Estève P.O., Robledo O., Vanthemsche C., Potworowski E.F., and St-Pierre Y. Evidence for the role of promoter methylation in the regulation of MMP-9 gene expression. Biochem. Biophys. Res. Commun. 297 (2002) 765-772
27. Arlt M., Kopitz C., Pennington C., Watson K.L., Krell H.W., Bode W., Gansbacher B., Khokha R., Edwards D.R., and Kruger A. Increase in gelatinase-specificity of matrix metalloproteinase inhibitors correlates with antimetastatic efficacy in a T-cell lymphoma model. Cancer Res. 62 (2002) 5543-5550